Acquisition - August 22, 2014
Pfizer could set eyes on AstraZeneca again
Pfizer could still be interested in buying AstraZeneca, reports Bloomberg refering to individuals with insight into the matter. Pfizer may not get a great shot at buying AstraZeneca this fall but it’s however preparing to give it a try. Meanwhile, Bloomberg reports, the U.S.-based drug giant is looking at Actavis among other targets. The Pfizer management […]
Global report - August 11, 2014
Pfizer faces legal threat over Lipitor
Cases of women claiming Lipitor gave them diabetes is increasing. In 2012, lawsuits concerning Pfizer’s cholesterol fighter Lipitor began as the FDA announced a warning that statins, a type of cholesterol lowering medicines, could have negative effects on memory and could also give a slightly increased risk of developing type 2 diabetes. The number of […]
Collaboration - June 18, 2014
Pfizer collaborates with Cellectis
The two companies have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies. Pfizer will get exclusive rights to pursue development and commercialization of CAR-T therapies, in the field of oncology, directed at a total of fifteen targets selected by Pfizer. Both companies will work together on preclinical research and Pfizer will […]
In a new job - May 26, 2014
New CEO for Pfizer AB
Malin Parkler will be the new CEO for Pfizer AB. Parkler will assume office in connection with Pfizer’s recent reorganisation. According to Pfizer, Malin Parkler has a wide experience from a number of positions within the company, most recently as business responsible for primary care products. Malin Parkler will succeed the previous CEO Edward Lysen. […]
Agreement - February 26, 2014
Saniona collaborates with Pfizer in million dollar agreement
The Danish biotechnology company has announced a drug developement collaboration with the global pharma giant. Saniona, previously known under the name Aniona, focuses on small molecule drug discovery within the ion channel field. The collaboration with Pfizer involves research on pharmaceuticals to treat neurological diseases and makes use of Saniona’s expertise within the ion channel field, […]
Collaboration - September 9, 2013
Karo Bio achieves milestone in Pfizer collaboration
The collaboration between Karo Bio and Pfizer has resulted in a significant achievement within the RORgamma project triggering the first milestone payment to Karo Bio. “The teams from Karo Bio and Pfizer have enjoyed an excellent interaction and relationship which has helped meet this goal. This achievement clearly demonstrates the value Karo Bio brings to […]
